FDA Adverse Event Injury Summary report: N

TALENT TAA STENT GRAFT

MDR report key: 8008377 · Received October 26, 2018

Report

Report Number
9612164-2018-02946
Event Type
Injury
Date Received
October 26, 2018
Date of Event
May 15, 2018
Report Date
January 15, 2019
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P070007
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

JOURNAL INFORMATION: TITLE: OUTCOMES OF PLANNED TWO-STAGE HYBRID AORTIC REPAIR WITH DACRON-REPLACED PROXIMAL LANDING ZONE AUTHORS:DAVID N. RANNEY, BABATUNDE A. YEROKUN, EHSAN BENRASHID, MUATH BISHAWI, ADAM WILLIAMS, RICHARD L. MCCANN AND G. CHAD HUGHES THE SOCIETY OF THORACIC SURGEONS, 2018;106:1136¿42, DOI.ORG/0.1016/J.ATHORACSUR.2018.04.044. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

UPDATED POST INVESTIGATION CLOSURE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

VALIANT AND TALENT SENT GRAFT SYSTEMS WERE IMPLANTED INTO 3 PATIENTS (OUT OF A STUDY GROUP OF 34 PATIENTS) FOR THE SECOND STAGE OF THORACIC AORTIC REPAIR FROM JANUARY 2006 AND AUGUST 2017. THE FIRST STAGE OF TREATMENT INVOLVED EITHER HYBRID ARCH REPAIR (HAR) OR TOTAL ARCH REPLACEMENT (TAR). IT WAS REPORTED THAT DURING THAT TIME THE FOLLOWING ADVERSE EVENTS WERE REPORTED IN THE ENTIRE PATIENT GROUP: SERIOUS INJURY STROKE PULMONARY EMBOLISM ALLERGIC REACTION CARDIO PULMONARY DISEASE SEPSIS RETROGRADE TYPE A DISSECTION REINTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
849466 TALENT TAA STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention